Adder­all sup­ply woes con­tin­ue as the FDA con­firms short­age of im­me­di­ate re­lease cap­sules

While it’s been on­ly a few days since more man­u­fac­tur­ers of gener­ic Adder­all cap­sules an­nounced up­com­ing short­ages, the FDA is al­so rais­ing con­cerns on the is­sue.

The reg­u­la­tor an­nounced that there was a short­age of the im­me­di­ate re­lease ver­sion of the gener­ic, which treats AD­HD and nar­colep­sy.

In a state­ment, the FDA said it is in com­mu­ni­ca­tion with all man­u­fac­tur­ers, with Te­va re­port­ing to the agency that it is ex­pe­ri­enc­ing “on­go­ing in­ter­mit­tent man­u­fac­tur­ing de­lays.” The FDA es­ti­mates that some prod­ucts will re­turn to stock this month, but some won’t be on the mar­ket un­til No­vem­ber or De­cem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER